BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8987871)

  • 1. Intracellular fate of 2-NBDG, a fluorescent probe for glucose uptake activity, in Escherichia coli cells.
    Yoshioka K; Saito M; Oh KB; Nemoto Y; Matsuoka H; Natsume M; Abe H
    Biosci Biotechnol Biochem; 1996 Nov; 60(11):1899-901. PubMed ID: 8987871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel fluorescent derivative of glucose applicable to the assessment of glucose uptake activity of Escherichia coli.
    Yoshioka K; Takahashi H; Homma T; Saito M; Oh KB; Nemoto Y; Matsuoka H
    Biochim Biophys Acta; 1996 Feb; 1289(1):5-9. PubMed ID: 8605231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntheses of 2-NBDG analogues for monitoring stereoselective uptake of D-glucose.
    Yamamoto T; Tanaka S; Suga S; Watanabe S; Nagatomo K; Sasaki A; Nishiuchi Y; Teshima T; Yamada K
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4088-96. PubMed ID: 21636274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid viability assessment of yeast cells using vital staining with 2-NBDG, a fluorescent derivative of glucose.
    Oh KB; Matsuoka H
    Int J Food Microbiol; 2002 Jun; 76(1-2):47-53. PubMed ID: 12038577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A real-time method of imaging glucose uptake in single, living mammalian cells.
    Yamada K; Saito M; Matsuoka H; Inagaki N
    Nat Protoc; 2007; 2(3):753-62. PubMed ID: 17406637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells.
    O'Neil RG; Wu L; Mullani N
    Mol Imaging Biol; 2005; 7(6):388-92. PubMed ID: 16284704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of a Fluorescent Analogue of Glucose (2-NBDG) versus Radiolabeled Sugars by Rumen Bacteria and Escherichia coli.
    Tao J; Diaz RK; Teixeira CR; Hackmann TJ
    Biochemistry; 2016 May; 55(18):2578-89. PubMed ID: 27096355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular binding and uptake of fluorescent glucose analogs 2-NBDG and 6-NBDG occurs independent of membrane glucose transporters.
    Hamilton KE; Bouwer MF; Louters LL; Looyenga BD
    Biochimie; 2021 Nov; 190():1-11. PubMed ID: 34224807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucose, a new fluorescent derivative of glucose, for viability assessment of yeast Candida albicans.
    Yoshioka K; Oh KB; Saito M; Nemoto Y; Matsuoka H
    Appl Microbiol Biotechnol; 1996 Nov; 46(4):400-4. PubMed ID: 8987729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-NBDG as a fluorescent indicator for direct glucose uptake measurement.
    Zou C; Wang Y; Shen Z
    J Biochem Biophys Methods; 2005 Sep; 64(3):207-15. PubMed ID: 16182371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant Uptake of a Fluorescent L-Glucose Analogue (fLG) into Tumor Cells Expressing Malignant Phenotypes.
    Yamada K
    Biol Pharm Bull; 2018; 41(10):1508-1516. PubMed ID: 30270319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel non-radioactive cell-based method for the screening of SGLT1 and SGLT2 inhibitors using 1-NBDG.
    Chang HC; Yang SF; Huang CC; Lin TS; Liang PH; Lin CJ; Hsu LC
    Mol Biosyst; 2013 Aug; 9(8):2010-20. PubMed ID: 23657801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel use of fluorescent glucose analogues to identify a new class of triazine-based insulin mimetics possessing useful secondary effects.
    Jung DW; Ha HH; Zheng X; Chang YT; Williams DR
    Mol Biosyst; 2011 Feb; 7(2):346-58. PubMed ID: 20927436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Existence of two parallel mechanisms for glucose uptake in heterotrophic plant cells.
    Etxeberria E; González P; Tomlinson P; Pozueta-Romero J
    J Exp Bot; 2005 Jul; 56(417):1905-12. PubMed ID: 15911561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of glucose uptake by single Escherichia coli cells.
    Natarajan A; Srienc F
    Metab Eng; 1999 Oct; 1(4):320-33. PubMed ID: 10937825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fluorescence method for measurement of glucose transport in kidney cells.
    Blodgett AB; Kothinti RK; Kamyshko I; Petering DH; Kumar S; Tabatabai NM
    Diabetes Technol Ther; 2011 Jul; 13(7):743-51. PubMed ID: 21510766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines.
    Millon SR; Ostrander JH; Brown JQ; Raheja A; Seewaldt VL; Ramanujam N
    Breast Cancer Res Treat; 2011 Feb; 126(1):55-62. PubMed ID: 20390344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining glucose transport in single vascular smooth muscle cells with a fluorescent glucose analog.
    Lloyd PG; Hardin CD; Sturek M
    Physiol Res; 1999; 48(6):401-10. PubMed ID: 10783904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery rate affects uptake of a fluorescent glucose analog in murine metastatic breast cancer.
    Rajaram N; Frees AE; Fontanella AN; Zhong J; Hansen K; Dewhirst MW; Ramanujam N
    PLoS One; 2013; 8(10):e76524. PubMed ID: 24204635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of fluorescent glucose bioprobes and their application on real-time and quantitative monitoring of glucose uptake in living cells.
    Lee HY; Lee JJ; Park J; Park SB
    Chemistry; 2011 Jan; 17(1):143-50. PubMed ID: 21207611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.